Table 3. HIV and HCV Testing and Results, by Location, in a Study Designed to Evaluate the Impact of Implementing HIV and HCV Screening in Community Pharmaciesa .
| Location | Pharmacies | HIV tests | Reactive HIV tests | HCV tests | Reactive HCV tests |
|---|---|---|---|---|---|
| Michigan, no. | 29 | 104 | 0 | 175 | 6 |
| West Virginia and Ohio, no. | 28 | 331 | 2 | 553 | 170 |
| Georgia, no. | 4 | 177 | 3 | 139 | 5 |
| All, no. (%) | 61 (100) | 612 (100) | 5 (0.8)b | 867 (100) | 181 (20.9)c |
Abbreviation: HCV, hepatitis C virus.
a
Study was conducted from July 2015 through August 2018. Sixty-one pharmacies participated in 3 US locations: Atlanta, Georgia; Detroit, Michigan; and Huntington/Charleston, West Virginia, along with Ohio communities neighboring the West Virginia border.
b
Denominator is number of HIV tests (5 of 612).
c
Denominator is number of HCV tests (181 of 867).